Technical Analysis for AKRO - Akero Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.75% | |
Multiple of Ten Bearish | Other | 0.75% | |
20 DMA Support | Bullish | -3.18% | |
Crossed Above 20 DMA | Bullish | -4.75% | |
Gapped Up | Strength | -4.75% | |
Fell Below 20 DMA | Bearish | -1.13% | |
Earnings Movers | Other | -1.13% | |
Gapped Up | Strength | -1.13% | |
Crossed Above 20 DMA | Bullish | -2.67% | |
Earnings Movers | Other | -2.67% |
Alert | Time |
---|---|
Up 2% | 31 minutes ago |
Up 1% | 38 minutes ago |
10 DMA Resistance | 3 days ago |
Down 3% | 3 days ago |
60 Minute Opening Range Breakdown | 3 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Akero Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of transformative treatments for patients with serious metabolic diseases with high unmet medical need. The company's lead program AKR-001 is being evaluated in a Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH).
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Alcohol Clinical Trial Hepatitis Steatohepatitis Metabolic Disease Non Alcoholic Fatty Liver Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Alcohol Clinical Trial Hepatitis Steatohepatitis Metabolic Disease Non Alcoholic Fatty Liver Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 58.38 |
52 Week Low | 11.25 |
Average Volume | 973,704 |
200-Day Moving Average | 27.08 |
50-Day Moving Average | 22.86 |
20-Day Moving Average | 20.40 |
10-Day Moving Average | 20.82 |
Average True Range | 1.26 |
RSI (14) | 42.86 |
ADX | 29.31 |
+DI | 11.57 |
-DI | 23.64 |
Chandelier Exit (Long, 3 ATRs) | 18.47 |
Chandelier Exit (Short, 3 ATRs) | 21.99 |
Upper Bollinger Bands | 21.99 |
Lower Bollinger Band | 18.81 |
Percent B (%b) | 0.35 |
BandWidth | 15.58 |
MACD Line | -0.51 |
MACD Signal Line | -0.65 |
MACD Histogram | 0.1428 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 21.50 | ||||
Resistance 3 (R3) | 21.63 | 21.22 | 21.24 | ||
Resistance 2 (R2) | 21.22 | 20.82 | 21.16 | 21.15 | |
Resistance 1 (R1) | 20.57 | 20.57 | 20.37 | 20.45 | 21.06 |
Pivot Point | 20.17 | 20.17 | 20.06 | 20.10 | 20.17 |
Support 1 (S1) | 19.52 | 19.76 | 19.31 | 19.39 | 18.78 |
Support 2 (S2) | 19.11 | 19.51 | 19.05 | 18.69 | |
Support 3 (S3) | 18.46 | 19.11 | 18.60 | ||
Support 4 (S4) | 18.34 |